SCHEMBL30922502

SCHEMBL30922502

CC1(C)OB(c2c3c(cc4c2cnn4C2CCCCO2)CCC3CCO[Si](C)(C)C(C)(C)C)OC1(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ RXRG P48443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30922617 0.85 RXRA (0.33) RXRARXRBRXRG
SCHEMBL31642613 0.85 RXRA (0.35) RXRARXRBRXRG
SCHEMBL30922830 0.81 RXRA (0.32) RXRARXRBRXRG
SCHEMBL30922414 0.81 RXRA (0.32) RXRARXRBRXRG
SCHEMBL30922878 0.81 RXRA (0.32) RXRARXRBRXRG
SCHEMBL30922623 0.79 RXRA (0.31) RXRARXRBRXRG
SCHEMBL30922972 0.79 RXRA (0.31) RXRARXRBRXRG
SCHEMBL30922510 0.79 CYP4F2 (0.33) RXRARXRBRXRG
SCHEMBL30922708 0.79 RXRA (0.31) RXRARXRBRXRG
SCHEMBL25795327 0.77 RXRA (0.40) RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598921-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE Amgen Inc. (US) 2025-08-13 — — EP disclosed
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 — — WO disclosed
Send feedback